Bridge Advisory, LLC Merck & Co., Inc. Transaction History

Bridge Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$102.95 - $114.33 $7,103 - $7,888	69 Added 2.73%	2,596 $267,000
Q2 2023 Jul 17, 2023	SELL	$108.61 - $118.38 $31,931 - $34,803	-294 Reduced 10.42%	2,527 $291,000
Q1 2023 Apr 14, 2023	BUY	$102.94 - $114.86 $52,705 - $58,808	512 Added 22.17%	2,821 $300,000
Q4 2022 Jan 17, 2023	BUY	$87.44 - $112.11 $201,898 - $258,861	2,309 New	2,309 $0
Q2 2022 Jul 13, 2022	BUY	$83.49 - $94.64 $200,292 - $227,041	2,399 New	2,399 $225,000
Q1 2022 Apr 18, 2022	SELL	$73.51 - $82.4 $206,489 - $231,461	-2,809 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $203,034 - $254,326	2,809 New	2,809 $215,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Bridge Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridge Advisory, LLC with notifications on news.